Revive Therapeutics Stock Forecast

Buy candidate since Jul 16, 2026 Gain 0.88%

The Revive Therapeutics Ltd stock price gained 0.88% on the last trading day (Friday, 17th Jul 2026), rising from $0.0228 to $0.0230. During the last trading day the stock fluctuated 4.13% from a day low at $0.0230 to a day high of $0.0240. The price has risen in 6 of the last 10 days and is up by 16.49% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 14 thousand more shares were traded than the day before. In total, 98 thousand shares were bought and sold for approximately $2.25 thousand.

The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $0.0244 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -22.72% during the next 3 months and, with a 90% probability hold a price between $0.0113 and $0.0189 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

RVVTF Signals & Forecast

The Revive Therapeutics Ltd stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $0.0217 and $0.0218. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Revive Therapeutics Ltd has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, July 09, 2026, and so far it has fallen -1.08%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Revive Therapeutics Ltd stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.0218 and $0.0200. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Revive Therapeutics Ltd finds support just below today's level at $0.0218. If this is broken, then the next support from accumulated volume will be at $0.0200 and $0.0184.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.0010 between high and low, or 4.13%. For the last week, the stock has had daily average volatility of 12.13%.

Our recommended stop-loss: $0.0221 (-4.06%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 6 days ago.)

Trading Expectations (RVVTF) For The Upcoming Trading Day Of Monday 20th

For the upcoming trading day on Monday, 20th we expect Revive Therapeutics Ltd to open at $0.0233, and during the day (based on 14 day Average True Range), to move between $0.0212 and $0.0248, which gives a possible trading interval of +/-$0.0035 (+/-16.62%) up or down from last closing price. If Revive Therapeutics Ltd takes out the full calculated possible swing range there will be an estimated 16.62% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.0218 (5.22%) than the resistance at $0.0244 (6.26%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Revive Therapeutics Ltd stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term.

Current score: 1.728 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 20, 2026 - $0.0233 ( 1.38%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk